Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

249 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Venetoclax in Relapsed or Refractory Hairy-Cell Leukemia.
Tiacci E, De Carolis L, Santi A, Falini B. Tiacci E, et al. Among authors: santi a. N Engl J Med. 2023 Mar 9;388(10):952-954. doi: 10.1056/NEJMc2216135. N Engl J Med. 2023. PMID: 36884329 No abstract available.
Constant activation of the RAF-MEK-ERK pathway as a diagnostic and therapeutic target in hairy cell leukemia.
Tiacci E, Schiavoni G, Martelli MP, Boveri E, Pacini R, Tabarrini A, Zibellini S, Santi A, Pettirossi V, Fortini E, Ascani S, Arcaini L, Inghirami G, Paulli M, Falini B. Tiacci E, et al. Among authors: santi a. Haematologica. 2013 Apr;98(4):635-9. doi: 10.3324/haematol.2012.078071. Epub 2013 Jan 24. Haematologica. 2013. PMID: 23349307 Free PMC article.
BRAF inhibitors reverse the unique molecular signature and phenotype of hairy cell leukemia and exert potent antileukemic activity.
Pettirossi V, Santi A, Imperi E, Russo G, Pucciarini A, Bigerna B, Schiavoni G, Fortini E, Spanhol-Rosseto A, Sportoletti P, Mannucci R, Martelli MP, Klein-Hitpass L, Falini B, Tiacci E. Pettirossi V, et al. Among authors: santi a. Blood. 2015 Feb 19;125(8):1207-16. doi: 10.1182/blood-2014-10-603100. Epub 2014 Dec 5. Blood. 2015. PMID: 25480661 Free PMC article. Clinical Trial.
Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma.
Tiacci E, Ladewig E, Schiavoni G, Penson A, Fortini E, Pettirossi V, Wang Y, Rosseto A, Venanzi A, Vlasevska S, Pacini R, Piattoni S, Tabarrini A, Pucciarini A, Bigerna B, Santi A, Gianni AM, Viviani S, Cabras A, Ascani S, Crescenzi B, Mecucci C, Pasqualucci L, Rabadan R, Falini B. Tiacci E, et al. Among authors: santi a. Blood. 2018 May 31;131(22):2454-2465. doi: 10.1182/blood-2017-11-814913. Epub 2018 Apr 12. Blood. 2018. PMID: 29650799 Free PMC article.
Safety and efficacy of the BRAF inhibitor dabrafenib in relapsed or refractory hairy cell leukemia: a pilot phase-2 clinical trial.
Tiacci E, De Carolis L, Simonetti E, Merluzzi M, Bennati A, Perriello VM, Pucciarini A, Santi A, Venanzi A, Pettirossi V, Schiavoni G, Tasselli L, Ascani S, Volpetti S, Falini B. Tiacci E, et al. Among authors: santi a. Leukemia. 2021 Nov;35(11):3314-3318. doi: 10.1038/s41375-021-01210-8. Epub 2021 Mar 17. Leukemia. 2021. PMID: 33731847 Free PMC article. Clinical Trial. No abstract available.
Dissecting Clonal Hematopoiesis in Tissues of Classical Hodgkin Lymphoma Patients.
Venanzi A, Marra A, Schiavoni G, Milner SG, Limongello R, Santi A, Pettirossi V, Ultimo S, Tasselli L, Pucciarini A, Falini L, Sciabolacci S, Martelli MP, Sportoletti P, Ascani S, Falini B, Tiacci E. Venanzi A, et al. Among authors: santi a. Blood Cancer Discov. 2021 May;2(3):216-225. doi: 10.1158/2643-3230.BCD-20-0203. Epub 2021 Apr 10. Blood Cancer Discov. 2021. PMID: 34164626 Free PMC article.
Hairy cell leukaemia with low CD103 expression: A rare but important diagnostic pitfall.
De Propris MS, Musiu P, Intoppa S, Nardacci MG, Pucciarini A, Santi A, Peragine N, Canichella M, De Luca ML, D'Elia GM, Del Giudice I, Pulsoni A, Falini B, Guarini A, Martelli M, Tiacci E, Foà R. De Propris MS, et al. Among authors: santi a. Br J Haematol. 2022 Jul;198(2):e28-e31. doi: 10.1111/bjh.18224. Epub 2022 May 2. Br J Haematol. 2022. PMID: 35499213 No abstract available.
The gene mutation landscape of acute myeloid leukemia cell lines and its exemplar use to study the BCOR tumor suppressor.
Pettirossi V, Venanzi A, Spanhol-Rosseto A, Schiavoni G, Santi A, Tasselli L, Naccari M, Pensato V, Pucciarini A, Martelli MP, Drexler H, Falini B, Tiacci E. Pettirossi V, et al. Among authors: santi a. Leukemia. 2023 Feb;37(2):473-477. doi: 10.1038/s41375-022-01788-7. Epub 2023 Jan 12. Leukemia. 2023. PMID: 36635390 No abstract available.
249 results